Marie Woe
Co-authored by Marie Woe of Haleon.
- Industry news
WHO issues global warning on fake Ozempic medication
The WHO has issued a global alert on falsified semaglutide products used to treat type 2 diabetes and obesity in some countries.
Co-authored by Marie Woe of Haleon.
2024-06-25T14:36:00
The WHO has issued a global alert on falsified semaglutide products used to treat type 2 diabetes and obesity in some countries.
The peer-reviewed journal, published 11 times per year and available free to TOPRA members.
The Organisation for Professionals in Regulatory Affairs
TOPRA office
TOPRA Publishing, 6th Floor, 3 Harbour Exchange, South Quay, London E14 9GE, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org
TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70
Site powered by Webvision Cloud